Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

This publication has 26 references indexed in Scilit:

• Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
  Journal of Clinical Oncology, 2003
• Targeting epidermal growth factor receptor—are we missing the mark?
  The Lancet, 2003
• Altered fractionation and combined radio-chemotherapy approaches
  European Journal Of Cancer, 2003
• Conventional vs modified fractionated radiotherapy. meta-analysis of radiotherapy in head & neck squamous cell carcinoma : a meta-analysis based on individual patient data
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
  The Lancet, 2000
• Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers
  Seminars in Radiation Oncology, 1996
• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
  Radiotherapy and Oncology, 1992
• The role of altered fractionation in head and neck cancers
  Seminars in Radiation Oncology, 1992
• Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Primary radiotherapy of larynx and pharynx carcinoma—An analysis of some factors influencing local control and survival
  International Journal of Radiation Oncology*Biology*Physics, 1986